Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Sanson

Showing results (211-220 of 290) with videos related to

Pageof 29
Sort By:
European Journal of Human Genetics : EJHG|August 13, 2015
Search for new loci and low-frequency variants influencing glioma risk by exome-array analysisBen Kinnersley, Yoichiro Kamatani, Marianne Labussière, et al.
Oncotarget|August 20, 2016
Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trialVéronique Quillien, Audrey Lavenu, François Ducray, et al.
Annals of Neurology|May 1, 2007
Dynamic history of low-grade gliomas before and after temozolomide treatmentDamien Ricard, Gentian Kaloshi, Alexandra Amiel-Benouaich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2010
IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor GroupMartin J van den Bent, Hendrikus J Dubbink, Yannick Marie, et al.
Neuro-Oncology|February 7, 2020
Imaging growth as a predictor of grade of malignancy and aggressiveness of IDH-mutant and 1p/19q-codeleted oligodendrogliomas in adultsAlexandre Roux, Arnault Tauziede-Espariat, Marc Zanello, et al.
Bulletin Du Cancer|January 7, 2004
[Standards, Options and Recommendations 2002 for the management of adult patients with intracranial gliomas (summary report)]Didier Frappaz, Olivier Chinot, Anne Bataillard, et al.
Frontiers in Cell and Developmental Biology|October 28, 2021
Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number AlterationsAmira Bouzidi, Karim Labreche, Marine Baron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2015
Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type GlioblastomasMaite Verreault, Charlotte Schmitt, Lauriane Goldwirt, et al.
Scientific Reports|December 3, 2015
Quantifying the heritability of glioma using genome-wide complex trait analysisBen Kinnersley, Jonathan S Mitchell, Konstantinos Gousias, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
A Catalytically Inactive Protein Kinase C alpha Mutation Drives Chordoid Glioma by Pathway RewiringCharlotte Bellamy, Hannah Tovell, Selina Schwaighofer, et al.
Pageof 29

Showing results (211-220 of 290) with videos related to

Sort By:
Pageof 29
European Journal of Human Genetics : EJHG|August 13, 2015
Search for new loci and low-frequency variants influencing glioma risk by exome-array analysisBen Kinnersley, Yoichiro Kamatani, Marianne Labussière, et al.
Oncotarget|August 20, 2016
Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trialVéronique Quillien, Audrey Lavenu, François Ducray, et al.
Annals of Neurology|May 1, 2007
Dynamic history of low-grade gliomas before and after temozolomide treatmentDamien Ricard, Gentian Kaloshi, Alexandra Amiel-Benouaich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2010
IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor GroupMartin J van den Bent, Hendrikus J Dubbink, Yannick Marie, et al.
Neuro-Oncology|February 7, 2020
Imaging growth as a predictor of grade of malignancy and aggressiveness of IDH-mutant and 1p/19q-codeleted oligodendrogliomas in adultsAlexandre Roux, Arnault Tauziede-Espariat, Marc Zanello, et al.
Bulletin Du Cancer|January 7, 2004
[Standards, Options and Recommendations 2002 for the management of adult patients with intracranial gliomas (summary report)]Didier Frappaz, Olivier Chinot, Anne Bataillard, et al.
Frontiers in Cell and Developmental Biology|October 28, 2021
Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number AlterationsAmira Bouzidi, Karim Labreche, Marine Baron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2015
Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type GlioblastomasMaite Verreault, Charlotte Schmitt, Lauriane Goldwirt, et al.
Scientific Reports|December 3, 2015
Quantifying the heritability of glioma using genome-wide complex trait analysisBen Kinnersley, Jonathan S Mitchell, Konstantinos Gousias, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
A Catalytically Inactive Protein Kinase C alpha Mutation Drives Chordoid Glioma by Pathway RewiringCharlotte Bellamy, Hannah Tovell, Selina Schwaighofer, et al.
Pageof 29